Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.33355 | 78 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.41434 | 78 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.37322 | 78 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.26652 | 89 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.2928 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.10651 | 77 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.32685 | 79 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.11846 | 76 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.30192 | 77 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.31902 | 77 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.32018 | 78 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.57974 | 79 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.23431 | 77 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.06466 | 76 |